Global Needle Free Injection Systems Market – Forecasts to 2021
The global needle free injection systems market has witnessed a substantial growth in recent years. The growing prevalence of chronic diseases, increase in the demand for needle free injection systems for eradicating the risks from needles and rise in the usage of self-injection systems worldwide are the key factors propelling the growth of the needle free injection systems market.
Europe is the fastest growing region in the global needle free injection systems market. The growth of European region is attributed to increase in the number of regulatory approvals for new injection systems, rise in healthcare expenditure, favourable government policies and regulations pertaining to healthcare compensation and growing prevalence of chronic diseases.
Request for Sample Report – https://www.gmiresearch.com/report/global-needle-free-injection-systems-market/sample-request
This research report on global needle free injection systems market provides in-depth analysis of the global needle free injection systems market based on product, technology and major geographies for the period from 2016 to 2021. The report highlights the major market drivers pushing the growth and challenges faced by market participants. The research report provides market size and forecast for needle free injection systems market. The report also analyses the competitive landscape and the major player and their market share in 2016. The competitive landscape section of the report also captures and highlights the recent development in the market.
The report also profiles the major companies active in this field, including Antares Pharma, Inc., Endo International PLC., Pharmajet, Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.) , Medical International Technology, Inc. (MIT) , Injex Pharma AG , National Medical Products, Inc. , Valeritas, Inc. , European Pharma Group, Penject Corporation , Crossject.
Request for Customization – https://www.gmiresearch.com/report/global-needle-free-injection-systems-market/request-for-customization
For Additional Insights, Click to Access Complete Report – https://www.gmiresearch.com/report/global-needle-free-injection-systems-market/
About GMI Research
GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research’s leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our client’s business problems and add significant value to long lasting relationship.
The company provides syndicated research report, customized research, sales enablement research, data analytics and KPO (knowledge process outsourcing) service for Electronics & Semiconductors, Information Communication and Technology, Energy & Power, Healthcare, Automotive, Transportation & Logistics and Chemical industries. Our analysts and consultants who are passionate about research and consulting are recruited from renowned local and global universities and have worked with the leading local and international organizations.
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Phone: 353 1 442 8820
Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate